Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Comment by billy4325on Apr 20, 2019 1:47pm
74 Views
Post# 29651122

RE:RE:RE:So much promise, so little execution

RE:RE:RE:So much promise, so little executionThe CEO has put out forward looking information to investors which have turned out to not be close to actual timeframes (in terms of completing transition to the new plant, completion of PGX deals, starting of cholesterol trials etc.).  I wouldn't be at all surprised if the "better than anyone" claim is an exaggeration to put it mildly.

trek01 wrote:
dando127 wrote: The goal of any corporation should be to "create wealth for shareholders"


Exactly, that's why I don't get why they don't try the cannabis market. CEO even said they would be better then anyone with extraction. But they dont want to do it and are not explaining us why. Its a huge opportunity that why are missing on. Why they dont try to do CBD-betaglucan "functional" drink. Or THC. Shouldnt be so hard to do it at different location if they are affraid of cannabis licencing. Why they cant just licence the PGX to cannabis companies.

The company would get way more interest from investors and dont tell me that they dont want that. 


Bullboard Posts